• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用证据撰写公共卫生政策政府报告:对 17 份挪威官方报告(NOU)的分析。

The use of evidence in public governmental reports on health policy: an analysis of 17 Norwegian official reports (NOU).

机构信息

Faculty of Social Sciences, Oslo University College, PO Box 4, St Olavs plass, 0130 Oslo, Norway.

出版信息

BMC Health Serv Res. 2009 Sep 28;9:177. doi: 10.1186/1472-6963-9-177.

DOI:10.1186/1472-6963-9-177
PMID:19785760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2761392/
Abstract

BACKGROUND

Governments increasingly require policy documents to be evidence-based. This paper analyses the use of scientific evidence in such documents by reviewing reports from government-appointed committees in Norway to assess the committees' handling of questions of effect.

METHODS

This study uses the 'Index of Scientific Quality' (ISQ) to analyse all Norwegian official reports (NOUs) that were: (1) published by the Norwegian Ministry of Health and Care Services during 1994-1998 (N = 20); and (2) concerned with questions of effect either because these were included in the mandate or as a result of the committee's interpretation of the mandate. The ISQ is based on scientific criteria common in all research concerning questions of effect. The primary outcome measure is an ISQ score on a five-point scale.

RESULTS

Three reports were excluded because their mandates, or the committees' interpretations of them, did not address questions of effect. For the remaining 17 NOUs in our study, overall ISQ scores were low for systematic literature search and for explicit validation of research. Two reports had an average score of three or higher, while scores for five other reports were not far behind. How committees assessed the relevant factors was often unclear.

CONCLUSION

The reports' evaluations of health evidence in relation to questions of effect lacked transparency and, overall, showed little use of systematic processes. A systematic, explicit and transparent approach, following the standards laid down in the ISQ, may help generate the evidence-based decision-making that Norway, the UK, the EU and the WHO desire and seek. However, policy-makers may find the ISQ criteria for assessing the scientific quality of a report too narrow to adequately inform policy-making.

摘要

背景

政府越来越要求政策文件要有证据支持。本文通过审查挪威政府任命的委员会的报告,分析这些文件中科学证据的使用情况,以评估委员会在处理效果问题上的处理方式。

方法

本研究使用“科学质量指数”(ISQ)分析所有挪威官方报告(NOU),这些报告:(1)1994-1998 年由挪威卫生和保健服务部出版(N=20);(2)涉及效果问题,要么是因为这些问题包含在任务中,要么是因为委员会对任务的解释。ISQ 基于所有涉及效果问题的研究中常见的科学标准。主要的结果衡量标准是五分制的 ISQ 得分。

结果

有三份报告因任务或委员会对任务的解释不涉及效果问题而被排除在外。在我们的研究中,对于其余的 17 份 NOU,系统文献检索和明确验证研究的整体 ISQ 得分较低。两份报告的平均得分为三或更高,而另外五份报告的得分也相差不远。委员会如何评估相关因素往往不清楚。

结论

报告中对与效果问题相关的健康证据的评估缺乏透明度,总体上显示出对系统过程的使用很少。遵循 ISQ 规定的标准,采用系统、明确和透明的方法,可能有助于产生挪威、英国、欧盟和世卫组织所希望和寻求的循证决策。然而,政策制定者可能会发现 ISQ 评估报告科学质量的标准过于狭窄,无法充分为决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be14/2761392/89b5010dcc03/1472-6963-9-177-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be14/2761392/a9a9ce3c509b/1472-6963-9-177-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be14/2761392/30df32cbf54c/1472-6963-9-177-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be14/2761392/89b5010dcc03/1472-6963-9-177-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be14/2761392/a9a9ce3c509b/1472-6963-9-177-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be14/2761392/30df32cbf54c/1472-6963-9-177-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be14/2761392/89b5010dcc03/1472-6963-9-177-3.jpg

相似文献

1
The use of evidence in public governmental reports on health policy: an analysis of 17 Norwegian official reports (NOU).利用证据撰写公共卫生政策政府报告:对 17 份挪威官方报告(NOU)的分析。
BMC Health Serv Res. 2009 Sep 28;9:177. doi: 10.1186/1472-6963-9-177.
2
Evidence-based medicine - an appropriate tool for evidence-based health policy? A case study from Norway.循证医学——制定循证卫生政策的合适工具?来自挪威的一个案例研究。
Health Res Policy Syst. 2016 Mar 5;14:15. doi: 10.1186/s12961-016-0088-1.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
5
[Expert committees in German public health policymaking during the SARS-CoV-2 pandemic: a document analysis].[新冠疫情期间德国公共卫生政策制定中的专家委员会:文献分析]
Z Evid Fortbild Qual Gesundhwes. 2021 Oct;165:1-12. doi: 10.1016/j.zefq.2021.06.002. Epub 2021 Aug 30.
6
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
7
Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.安抚奶嘴使用与母乳喂养、婴儿猝死综合征、感染及牙列不齐之间的关联。
JBI Libr Syst Rev. 2005;3(6):1-33. doi: 10.11124/01938924-200503060-00001.
8
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
9
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
10
Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.巴西国家 HTA 机构决策过程面临的挑战:操作程序、证据使用和建议。
Health Res Policy Syst. 2018 May 11;16(1):40. doi: 10.1186/s12961-018-0319-8.

引用本文的文献

1
The construction of the responsible patient in complex palliative care: interpreting palliative care policies.复杂姑息治疗中责任患者的构建:解读姑息治疗政策。
Palliat Care Soc Pract. 2022 Aug 29;16:26323524221118586. doi: 10.1177/26323524221118586. eCollection 2022.
2
Priority setting and personal health responsibility: an analysis of Norwegian key policy documents.优先事项设定和个人健康责任:对挪威主要政策文件的分析。
J Med Ethics. 2022 Jan;48(1):39-45. doi: 10.1136/medethics-2019-105612. Epub 2020 Mar 2.
3
How was research engaged with and used in the development of 131 policy documents? Findings and measurement implications from a mixed methods study.

本文引用的文献

1
Recognizing rhetoric in health care policy analysis.认识医疗保健政策分析中的修辞手法。
J Health Serv Res Policy. 2008 Jan;13(1):40-6. doi: 10.1258/jhsrp.2007.006029.
2
Knowledge transfer and exchange: review and synthesis of the literature.知识转移与交流:文献综述与综合
Milbank Q. 2007 Dec;85(4):729-68. doi: 10.1111/j.1468-0009.2007.00506.x.
3
Use of evidence in WHO recommendations.证据在世卫组织建议中的应用。
研究如何参与并应用于 131 项政策文件的制定?一项混合方法研究的发现和衡量意义。
Implement Sci. 2019 Apr 30;14(1):44. doi: 10.1186/s13012-019-0886-2.
4
Communication of scientific uncertainty: international case studies on the development of folate and vitamin D Dietary Reference Values.科学不确定性的沟通:叶酸和维生素D膳食参考值制定的国际案例研究
Public Health Nutr. 2015 Jun;18(8):1378-88. doi: 10.1017/S1368980014002006. Epub 2014 Sep 23.
5
New directions in evidence-based policy research: a critical analysis of the literature.循证政策研究的新方向:文献的批判性分析
Health Res Policy Syst. 2014 Jul 14;12:34. doi: 10.1186/1478-4505-12-34.
6
A systematic review of barriers to and facilitators of the use of evidence by policymakers.政策制定者使用证据的障碍与促进因素的系统评价
BMC Health Serv Res. 2014 Jan 3;14:2. doi: 10.1186/1472-6963-14-2.
Lancet. 2007 Jun 2;369(9576):1883-1889. doi: 10.1016/S0140-6736(07)60675-8.
4
Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines.影响发展中国家卫生政策制定者利用研究结果的因素:以马里基本药物的选择为例
Health Res Policy Syst. 2007 Mar 5;5:2. doi: 10.1186/1478-4505-5-2.
5
Evidence-based management.循证管理
Harv Bus Rev. 2006 Jan;84(1):62-74, 133.
6
Towards systematic reviews that inform health care management and policy-making.迈向为医疗保健管理和政策制定提供信息的系统评价。
J Health Serv Res Policy. 2005 Jul;10 Suppl 1:35-48. doi: 10.1258/1355819054308549.
7
Realist review--a new method of systematic review designed for complex policy interventions.现实主义综述——一种为复杂政策干预设计的系统综述新方法。
J Health Serv Res Policy. 2005 Jul;10 Suppl 1:21-34. doi: 10.1258/1355819054308530.
8
Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field.系统地审查定性和定量证据,以为卫生领域的管理和决策提供信息。
J Health Serv Res Policy. 2005 Jul;10 Suppl 1:6-20. doi: 10.1258/1355819054308576.
9
Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review.创新扩散研究的故事情节:一种系统综述的元叙事方法。
Soc Sci Med. 2005 Jul;61(2):417-30. doi: 10.1016/j.socscimed.2004.12.001. Epub 2005 Jan 26.
10
Evidence-based health policy: context and utilisation.循证健康政策:背景与应用
Soc Sci Med. 2004 Jan;58(1):207-17. doi: 10.1016/s0277-9536(03)00166-7.